Jan Magnus Aronsen

Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure

Ida G. Lunde, Jan Magnus Aronsen, Heidi Kvaløy et al. · Physiological Genomics · 2011 · 195 citations

Life Sciences, Biochemistry, Cardiology +13

The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy

Bernard Thienpont, Jan Magnus Aronsen, Emma Robinson et al. · Journal of Clinical Investigation · 2016 · 128 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2

Anna Zoccarato, Nicoletta C. Surdo, Jan Magnus Aronsen et al. · Circulation Research · 2015 · 126 citations · Full text

Life Sciences, Cardiology, Pharmacology +16

Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction

Michael Frisk, Christopher Le, Xin Shen et al. · Journal of the American College of Cardiology · 2021 · 125 citations · Full text

Medicine, Cardiology, Physiology +14

Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes

Terje R. Kolstad, Jonas van den Brink, Niall Macquaide et al. · eLife · 2018 · 119 citations · Full text

Life Sciences, Cardiology, Physiology +17